Morepen Labs net profit leaps over 6 fold to Rs 27crore in Q2
New Delhi: Drug firm Dr Morepen Laboratories on Monday reported an over six-fold jump in its consolidated net profit to Rs 27.16 crore for the quarter ended September, on account of robust sales. The company had posted a net profit of Rs 4.08 crore for the corresponding period of the previous fiscal, Morepen Labs said in a BSE filing.Total revenue stood at Rs 340.12 crore for the quarter...
New Delhi: Drug firm Dr Morepen Laboratories on Monday reported an over six-fold jump in its consolidated net profit to Rs 27.16 crore for the quarter ended September, on account of robust sales. The company had posted a net profit of Rs 4.08 crore for the corresponding period of the previous fiscal, Morepen Labs said in a BSE filing.
Read also: Morepen Labs net profit leaps over two-fold to Rs 19.36 crore in Q1
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd